These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 25027708)

  • 41. A novel mucosal vaccine targeting Peyer's patch M cells induces protective antigen-specific IgA responses.
    Shima H; Watanabe T; Fukuda S; Fukuoka S; Ohara O; Ohno H
    Int Immunol; 2014 Nov; 26(11):619-25. PubMed ID: 24908678
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Virus-like particles derived from Pichia pastoris-expressed dengue virus type 1 glycoprotein elicit homotypic virus-neutralizing envelope domain III-directed antibodies.
    Poddar A; Ramasamy V; Shukla R; Rajpoot RK; Arora U; Jain SK; Swaminathan S; Khanna N
    BMC Biotechnol; 2016 Jun; 16(1):50. PubMed ID: 27301568
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Development of a pilot-scale production process and characterization of a recombinant Japanese encephalitis virus envelope domain III protein expressed in Escherichia coli.
    Tripathi NK; Shrivastava A; Biswal KC; Rao PV
    Appl Microbiol Biotechnol; 2012 Sep; 95(5):1179-89. PubMed ID: 22562165
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Generation and characterization of a monoclonal antibody that cross-reacts with the envelope protein from the four dengue virus serotypes.
    León-Juárez M; García-Cordero J; Santos-Argumedo L; Romero-Ramírez H; García-Machorro J; Bustos-Arriaga J; Gutiérrez-Castañeda B; Sepúlveda NV; Mellado-Sánchez G; Cedillo-Barrón L
    APMIS; 2013 Sep; 121(9):848-58. PubMed ID: 23331315
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Casamino acids facilitate the secretion of recombinant dengue virus serotype-3 envelope domain III in Pichia pastoris.
    Kaushik N; Rohila D; Arora U; Raut R; Lamminmäki U; Khanna N; Batra G
    BMC Biotechnol; 2016 Feb; 16():12. PubMed ID: 26847361
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Recombinant dengue virus type 3 envelope domain III protein from Escherichia coli.
    Tripathi NK; Shrivastava A; Biswal KC; Rao PV
    Biotechnol J; 2011 May; 6(5):604-8. PubMed ID: 21538895
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A novel fusion protein domain III-capsid from dengue-2, in a highly aggregated form, induces a functional immune response and protection in mice.
    Valdés I; Bernardo L; Gil L; Pavón A; Lazo L; López C; Romero Y; Menendez I; Falcón V; Betancourt L; Martín J; Chinea G; Silva R; Guzmán MG; Guillén G; Hermida L
    Virology; 2009 Nov; 394(2):249-58. PubMed ID: 19783271
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Human monoclonal single-chain antibodies specific to dengue virus envelope protein.
    Saokaew N; Poungpair O; Panya A; Tarasuk M; Sawasdee N; Limjindaporn T; Chaicumpa W; Yenchitsomanus P
    Lett Appl Microbiol; 2014 Mar; 58(3):270-7. PubMed ID: 24266517
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Trichinella spiralis: intranasal immunization with attenuated Salmonella enterica carrying a gp43 antigen-derived 30mer epitope elicits protection in BALB/c mice.
    Pompa-Mera EN; Yépez-Mulia L; Ocaña-Mondragón A; García-Zepeda EA; Ortega-Pierres G; González-Bonilla CR
    Exp Parasitol; 2011 Dec; 129(4):393-401. PubMed ID: 21907709
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Recombinant interleukin 6 with M cell-targeting moiety produced in Lactococcus lactis IL1403 as a potent mucosal adjuvant for peroral immunization.
    Li HS; Piao DC; Jiang T; Bok JD; Cho CS; Lee YS; Kang SK; Choi YJ
    Vaccine; 2015 Apr; 33(16):1959-67. PubMed ID: 25738814
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Induction of an immune response to transmissible gastroenteritis coronavirus using vectors with enteric tropism.
    Smerdou C; Torres JM; Sánchez CM; Suñé C; Antón IM; Medina M; Castilla J; Graham FL; Enjuanes L
    Adv Exp Med Biol; 1993; 342():455-62. PubMed ID: 7516110
    [No Abstract]   [Full Text] [Related]  

  • 52. Candida albicans TDH3 gene promotes secretion of internal invertase when expressed in Saccharomyces cerevisiae as a glyceraldehyde-3-phosphate dehydrogenase-invertase fusion protein.
    Delgado ML; Gil ML; Gozalbo D
    Yeast; 2003 Jun; 20(8):713-22. PubMed ID: 12794932
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Induction of bivalent immune responses by expression of dengue virus type 1 and type 2 antigens from a single complex adenoviral vector.
    Raja NU; Holman DH; Wang D; Raviprakash K; Juompan LY; Deitz SB; Luo M; Zhang J; Porter KR; Dong JY
    Am J Trop Med Hyg; 2007 Apr; 76(4):743-51. PubMed ID: 17426182
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Expression of env sequences of the bovine leukemia virus (BLV) in the yeast Saccharomyces cerevisiae.
    Brantl S; Eldarov MA; Rössler H; Drescher B; Lang H; Rosenthal S; Skryabin KG
    Yeast; 1988 Mar; 4(1):47-59. PubMed ID: 2849260
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A custom-designed recombinant multiepitope protein as a dengue diagnostic reagent.
    AnandaRao R; Swaminathan S; Fernando S; Jana AM; Khanna N
    Protein Expr Purif; 2005 May; 41(1):136-47. PubMed ID: 15802231
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Oral immunisation of mice with transgenic rice calli expressing cholera toxin B subunit fused to consensus dengue cEDIII antigen induces antibodies to all four dengue serotypes.
    Kim MY; Kim BY; Oh SM; Reljic R; Jang YS; Yang MS
    Plant Mol Biol; 2016 Oct; 92(3):347-56. PubMed ID: 27566485
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Tetravalent neutralizing antibody response against four dengue serotypes by a single chimeric dengue envelope antigen.
    Apt D; Raviprakash K; Brinkman A; Semyonov A; Yang S; Skinner C; Diehl L; Lyons R; Porter K; Punnonen J
    Vaccine; 2006 Jan; 24(3):335-44. PubMed ID: 16125280
    [TBL] [Abstract][Full Text] [Related]  

  • 58. EDIII-DENV3 nanospheres drive immature dendritic cells into a mature phenotype in an in vitro model.
    Nantachit N; Sunintaboon P; Ubol S
    Microbiol Immunol; 2017 Aug; 61(8):305-317. PubMed ID: 28603864
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Serotype-specificity of recombinant fusion proteins containing domain III of dengue virus.
    Izquierdo A; Bernardo L; Martin J; Santana E; Hermida L; Guillén G; Guzmán MG
    Virus Res; 2008 Dec; 138(1-2):135-8. PubMed ID: 18796319
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Evaluation of chimeric DNA vaccines consisting of premembrane and envelope genes of Japanese encephalitis and dengue viruses as a strategy for reducing induction of dengue virus infection-enhancing antibody response.
    Sjatha F; Kuwahara M; Sudiro TM; Kameoka M; Konishi E
    Microbiol Immunol; 2014 Feb; 58(2):126-34. PubMed ID: 24372832
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.